XML 56 R45.htm IDEA: XBRL DOCUMENT v3.21.2
Schedule of Stock Option Activity (Details) - USD ($)
9 Months Ended
Jun. 24, 2020
Sep. 30, 2021
2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Granted   3,035,800
2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Granted   230,770
Non-qualified Stock Options [Member] | 2017 Equity Incentive Plan [Member] | Employees And Consultants [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Outstanding Beginning   14,251,000
Weighted Average Exercise Price, Outstanding Beginning   $ 0.083
Weighted Average Remaining Contractual Term, Outstanding Beginning   8 years 3 months 18 days
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted   3,035,800
Weighted Average Exercise Price, Granted   $ 0.085
Weighted Average Remaining Contractual Term, Granted   10 years
Aggregate Intrinsic Value, Granted  
Number of Options, Exercised  
Number of Options, Forfeited/Cancelled   (287,000)
Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price   $ 0.122
[custom:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTermForfeited]   6 years 7 months 6 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value  
Number of Options, Expired  
Number of Options, Outstanding Ending   16,999,800
Weighted Average Exercise Price, Outstanding Ending   $ 0.083
Weighted Average Remaining Contractual Term, Outstanding Ending   7 years 10 months 24 days
Aggregate Intrinsic Value, Outstanding Ending  
Number of Options, Exercisable Ending   15,249,800
Weighted Average Exercise Price, Exercisable Ending   $ 0.085
Weighted Average Remaining Contractual Term, Exercisable Ending   7 years 8 months 12 days
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Forfeited/Cancelled   287,000
Aggregate Intrinsic Value, Outstanding Ending  
Non-qualified Stock Options [Member] | 2017 Equity Incentive Plan [Member] | Directors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Weighted Average Remaining Contractual Term, Outstanding Beginning 5 years  
Non-qualified Stock Options [Member] | 2017 Equity Plan and 2021 Equity Plan [Member] | Directors [Member]    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]    
Number of Options, Outstanding Beginning   7,400,000
Weighted Average Exercise Price, Outstanding Beginning   $ 0.067
Weighted Average Remaining Contractual Term, Outstanding Beginning   7 years 6 months
Aggregate Intrinsic Value, Outstanding Beginning  
Number of Options, Granted   230,770
Weighted Average Exercise Price, Granted   $ 0.065
Weighted Average Remaining Contractual Term, Granted   10 years
Aggregate Intrinsic Value, Granted  
Number of Options, Exercised  
Number of Options, Forfeited/Cancelled  
Number of Options, Expired  
Number of Options, Outstanding Ending   7,630,770
Weighted Average Exercise Price, Outstanding Ending   $ 0.067
Weighted Average Remaining Contractual Term, Outstanding Ending   6 years 9 months 18 days
Aggregate Intrinsic Value, Outstanding Ending  
Number of Options, Exercisable Ending   7,630,770
Weighted Average Exercise Price, Exercisable Ending   $ 0.067
Weighted Average Remaining Contractual Term, Exercisable Ending   6 years 9 months 18 days
Aggregate Intrinsic Value, Exercisable Ending  
Number of Options, Forfeited/Cancelled  
Aggregate Intrinsic Value, Outstanding Ending